Bingham Osborn & Scarborough’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,864
| Closed | -$200K | – | 55 |
|
|
2021
Q3 | $200K | Buy |
+2,864
| New | +$200K | 0.01% | 156 |
|
|
2016
Q3 | – | Sell |
-3,867
| Closed | -$323K | – | 113 |
|
|
2016
Q2 | $323K | Sell |
3,867
-14
| -0.4% | -$1.17K | 0.04% | 89 |
|
|
2016
Q1 | $357K | Buy |
3,881
+3
| +0.1% | +$276 | 0.04% | 85 |
|
|
2015
Q4 | $392K | Hold |
3,878
| – | – | 0.05% | 77 |
|
|
2015
Q3 | $381K | Sell |
3,878
-608
| -14% | -$59.7K | 0.05% | 75 |
|
|
2015
Q2 | $525K | Hold |
4,486
| – | – | 0.06% | 66 |
|
|
2015
Q1 | $440K | Hold |
4,486
| – | – | 0.05% | 72 |
|
|
2014
Q4 | $423K | Sell |
4,486
-480
| -10% | -$45.3K | 0.05% | 75 |
|
|
2014
Q3 | $529K | Buy |
4,966
+480
| +11% | +$51.1K | 0.07% | 70 |
|
|
2014
Q2 | $372K | Sell |
4,486
-200
| -4% | -$16.6K | 0.05% | 71 |
|
|
2014
Q1 | $332K | Sell |
4,686
-550
| -11% | -$39K | 0.05% | 76 |
|
|
2013
Q4 | $393K | Hold |
5,236
| – | – | 0.06% | 65 |
|
|
2013
Q3 | $329K | Hold |
5,236
| – | – | 0.05% | 65 |
|
|
2013
Q2 | $268K | Buy |
+5,236
| New | +$268K | 0.05% | 67 |
|